CAPR EPS Estimates
Capricor Therapeutics, Inc.
$6.59
-$0.29(-4.22%)
38
Overall
60
Value
10
Tech
44
Quality
Market Cap
$383.14M
Volume
2.51M
52W Range
$2.96 - $40.37
Target Price
$23.67
CAPR EPS estimates: the consensus estimate for Capricor Therapeutics, Inc.'s current fiscal year is -$1.71 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
CAPR EPS Estimates
- EPS estimate, current quarter
- $-0.61
- EPS estimate, next quarter
- $0.12
- EPS estimate, current year
- $-1.71
- EPS estimate, next year
- $-1.19
- EPS growth, 3-year
- -24.19%
| Fiscal year | EPS |
|---|---|
| 2025 | $-2.26 |
| 2024 | $-1.15 |
| 2023 | $-0.83 |
| 2022 | $-1.18 |
| 2021 | $-0.87 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | CAPR | $6.59 | -4.2% | 2.51M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Capricor Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW